← Evidence map

ArticleOncotarget2016

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival.

Qianqian Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27833085